Compare AANJANEYA LIFECARE with Fresenius Kabi Onco. - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

DR. DATSONS LABS vs FRESENIUS KABI ONCO. - Comparison Results

FRESENIUS KABI ONCO. 
   Change

Fresenius Kabi Oncology is the erstwhile Dabur Pharma, which was incorporated in March 2003. The company is a leading player in oncology in India and the international markets. Fresenius Kabi Oncology operates in the regulated markets namely the US a... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    DR. DATSONS LABS FRESENIUS KABI ONCO. DR. DATSONS LABS/
FRESENIUS KABI ONCO.
 
P/E (TTM) x -10.9 22.1 - View Chart
P/BV x 0.2 3.1 5.2% View Chart
Dividend Yield % 0.0 0.0 -  

Financials

 DR. DATSONS LABS   FRESENIUS KABI ONCO.
EQUITY SHARE DATA
    DR. DATSONS LABS
Mar-14
FRESENIUS KABI ONCO.
Mar-13
DR. DATSONS LABS/
FRESENIUS KABI ONCO.
5-Yr Chart
Click to enlarge
High Rs126176 71.4%   
Low Rs3179 39.4%   
Sales per share (Unadj.) Rs133.037.7 352.9%  
Earnings per share (Unadj.) Rs0.25.1 3.0%  
Cash flow per share (Unadj.) Rs6.66.7 98.3%  
Dividends per share (Unadj.) Rs00-  
Dividend yield (eoy) %00-  
Book value per share (Unadj.) Rs128.842.5 302.7%  
Shares outstanding (eoy) m31.66158.23 20.0%   
Bonus/Rights/Conversions FCCB--  
Price / Sales ratio x0.63.4 17.4%   
Avg P/E ratio x516.125.0 2,065.8%  
P/CF ratio (eoy) x11.818.9 62.6%  
Price / Book Value ratio x0.63.0 20.3%  
Dividend payout %00-   
Avg Mkt Cap Rs m2,47720,135 12.3%   
No. of employees `000NA1.2 0.0%   
Total wages/salary Rs m56703 8.0%   
Avg. sales/employee Rs ThNM5,176.2-  
Avg. wages/employee Rs ThNM610.4-  
Avg. net profit/employee Rs ThNM699.6-  
INCOME DATA
Net Sales Rs m4,2115,963 70.6%  
Other income Rs m7918 437.2%   
Total revenues Rs m4,2895,981 71.7%   
Gross profit Rs m5691,430 39.8%  
Depreciation Rs m204258 79.3%   
Interest Rs m430-26 -1,654.6%   
Profit before tax Rs m131,216 1.0%   
Minority Interest Rs m00-   
Prior Period Items Rs m-20-   
Extraordinary Inc (Exp) Rs m0-68 0.0%   
Tax Rs m6342 1.8%   
Profit after tax Rs m5806 0.6%  
Gross profit margin %13.524.0 56.3%  
Effective tax rate %48.028.1 170.7%   
Net profit margin %0.113.5 0.8%  
BALANCE SHEET DATA
Current assets Rs m6,8525,102 134.3%   
Current liabilities Rs m6,7112,385 281.3%   
Net working cap to sales %3.345.6 7.4%  
Current ratio x1.02.1 47.7%  
Inventory Days Days161150 107.2%  
Debtors Days Days318113 281.1%  
Net fixed assets Rs m3,6735,148 71.3%   
Share capital Rs m317158 200.1%   
"Free" reserves Rs m3,7616,556 57.4%   
Net worth Rs m4,0786,732 60.6%   
Long term debt Rs m1,671952 175.5%   
Total assets Rs m12,63310,388 121.6%  
Interest coverage x1.0-45.8 -2.2%   
Debt to equity ratio x0.40.1 289.7%  
Sales to assets ratio x0.30.6 58.1%   
Return on assets %3.47.5 45.9%  
Return on equity %0.112.0 1.0%  
Return on capital %7.714.6 52.5%  
Exports to sales %22.974.5 30.7%   
Imports to sales %14.324.8 57.7%   
Exports (fob) Rs m9644,441 21.7%   
Imports (cif) Rs m6021,477 40.7%   
Fx inflow Rs m9645,298 18.2%   
Fx outflow Rs m6071,772 34.3%   
Net fx Rs m3573,525 10.1%   
CASH FLOW
From Operations Rs m1,3451,274 105.5%  
From Investments Rs m-2,256-1,204 187.3%  
From Financial Activity Rs m-1,200-196 611.8%  
Net Cashflow Rs m-2,111-126 1,671.2%  

Share Holding

Indian Promoters % 4.5 0.0 -  
Foreign collaborators % 0.0 81.0 -  
Indian inst/Mut Fund % 0.0 0.3 -  
FIIs % 1.4 9.6 14.1%  
ADR/GDR % 0.0 0.0 -  
Free float % 94.1 9.1 1,034.1%  
Shareholders   20,807 42,599 48.8%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare DR. DATSONS LABS With:   ALKEM LABORATORIES  DISHMAN PHARMA  TTK HEALTHCARE  TORRENT PHARMA  BIOCON   

Compare DR. DATSONS LABS With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Indian Stock Markets Open Flat; Metal and Telecom Stocks Lag(09:30 am)

Asian stock markets extended a global selloff today as China took more drastic steps to combat the coronavirus. Japan's Nikkei was 0.7% down, Australian shares stumbled 1.3%.

Related Views on News

MSTC IPO: Should You Bet on This State-Run E-Commerce Player? (IPO)

Mar 13, 2019

Should you subscribe to the IPO of MSPC Limited?

MSTC IPO: Should You Bet on This State-Run E-Commerce Player? (IPO)

Mar 13, 2019

Should you subscribe to the IPO of MSPC Limited?

Hindustan Aeronautics IPO: Yet Another Play on India's Defence Sector (IPO)

Mar 14, 2018

Should you apply for the IPO of state-run military aircraft maker Hindustan Aeronautics?

Bharat Dynamics IPO: Worth Betting on Defence Manufacturing? (IPO)

Mar 12, 2018

Should you apply for the IPO of Bharat Dynamics, India's first state-owned missile manufacturer?

Hindustan Aeronautics IPO: Yet Another Play on India's Defence Sector (IPO)

Mar 14, 2018

Should you apply for the IPO of state-run military aircraft maker Hindustan Aeronautics?

More Views on News

Most Popular

How to Buy the Best Safe Stocks in 2020(The 5 Minute Wrapup)

Jan 17, 2020

Don't fall for the safe stocks narrative going around in the stock market these days.

Guess Which Stocks Are Rising at Double the Speed of Sensex(Profit Hunter)

Jan 15, 2020

These stocks can move twice as fast as the Sensex - to take advantage of their money multiplying power get in now as the rally is still just taking shape.. read more to not miss out.

For 1,000%+ Gains, Follow the 8-Year Cycle in the Stock Market(Fast Profits Daily)

Jan 17, 2020

This is how the biggest trading profits are made.

What the Infosys Results Tell Us About the Next Infosys(The 5 Minute Wrapup)

Jan 15, 2020

If you're interested in the next Infosys, I'll tell you where to look.

The Best Asset Class to Invest in 2020(Fast Profits Daily)

Jan 24, 2020

Why I'm most bullish on this asset class above all else in 2020.

More

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get our special report, Secret to Increasing Your Trading Profits Today Now!
We will never sell or rent your email id.
Please read our Terms

DR. DATSONS LABS SHARE PRICE


May 21, 2015 (Close)

TRACK DR. DATSONS LABS

  • Track your investment in DR. DATSONS LABS with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON DR. DATSONS LABS

DR. DATSONS LABS 5-YR ANALYSIS

COMPARE DR. DATSONS LABS WITH

MARKET STATS